Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.

Verkindre C, Bart F, Aguilaniu B, Fortin F, Guérin JC, Le Merre C, Iacono P, Huchon G.

Respiration. 2006;73(4):420-7. Epub 2005 Nov 7.

PMID:
16484769
2.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
3.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105.

4.

Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.

Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.

Osaka City Med J. 2007 Jun;53(1):25-34.

PMID:
17867631
5.

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.

Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S; Tiotropium Multicentric Italian Study Group.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):771-80.

6.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

7.

[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].

Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N; ATEM-Studiengruppe.

Pneumologie. 2006 Jun;60(6):341-6. German.

PMID:
16761228
8.

Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD.

Johansson G, Lindberg A, Romberg K, Nordström L, Gerken F, Roquet A.

Prim Care Respir J. 2008 Sep;17(3):169-75. doi: 10.3132/pcrj.2008.00037.

9.
10.

Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease.

Covelli H, Bhattacharya S, Cassino C, Conoscenti C, Kesten S.

Pharmacotherapy. 2005 Dec;25(12):1708-18.

PMID:
16305289
11.

Tiotropium in COPD patients not previously receiving maintenance respiratory medications.

Adams SG, Anzueto A, Briggs DD Jr, Menjoge SS, Kesten S.

Respir Med. 2006 Sep;100(9):1495-503. Epub 2006 May 15.

12.

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD.

Tonnel AB, Perez T, Grosbois JM, Verkindre C, Bravo ML, Brun M; TIPHON study group.

Int J Chron Obstruct Pulmon Dis. 2008;3(2):301-10.

13.

Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.

Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V.

Respir Med. 2012 Jan;106(1):84-90. doi: 10.1016/j.rmed.2011.09.006. Epub 2011 Oct 27.

14.

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.

Thorax. 2008 Jul;63(7):592-8. doi: 10.1136/thx.2007.087213. Epub 2008 Feb 1.

PMID:
18245142
15.

Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.

Beeh KM, Korn S, Beier J, Jadayel D, Henley M, D'Andrea P, Banerji D.

Respir Med. 2014 Apr;108(4):584-92. doi: 10.1016/j.rmed.2014.01.006. Epub 2014 Jan 21.

16.

Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.

Casaburi R, Maltais F, Porszasz J, Albers F, Deng Q, Iqbal A, Paden HA, O'Donnell DE; 205.440 Investigators.

Ann Am Thorac Soc. 2014 Nov;11(9):1351-61. doi: 10.1513/AnnalsATS.201404-174OC.

PMID:
25289942
17.

Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.

Travers J, Laveneziana P, Webb KA, Kesten S, O'Donnell DE.

Respir Med. 2007 Sep;101(9):2017-24. Epub 2007 May 1.

18.

Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.

Fukuchi Y, Fernandez L, Kuo HP, Mahayiddin A, Celli B, Decramer M, Kesten S, Liu D, Tashkin D.

Respirology. 2011 Jul;16(5):825-35. doi: 10.1111/j.1440-1843.2011.01982.x. Erratum in: Respirology. 2011 Nov;16(8):1281.

PMID:
21539680
19.

[A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease].

Yin KS, Zhang DP, Shi Y, Sun LH, Min R, Xiao YL, Xia XR, Tan Y, Fu WZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Jul;33(7):519-23. Chinese.

PMID:
20979799
20.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045

Supplemental Content

Support Center